Regulation of Bcl-2 Expression by Dihydrotestosterone in Hormone Sensitive LNCaP-FGC Prostate Cancer Cells
Elizabeth Bruckheimer(The University of Texas MD Anderson Cancer Center), Timothy J. McDonnell(Health Service Executive), Christopher J. Logothetis(The University of Texas MD Anderson Cancer Center), Nancy L. Weigel(Baylor College of Medicine), Kevin B. Spurgers(The University of Texas MD Anderson Cancer Center)
Cited by 30
Related Papers
Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy
|New England Journal of Medicine|2012|2.8k
Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3
|Journal of Clinical Oncology|2016|1.6k
Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled phase 3 study
|The Lancet Oncology|2012|1.4k